InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Cumming John W, Director. Officer active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 4 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €18k. History available since 1 July 2021. The latest transaction was disclosed on 1 July 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
John W. Cumming is a Board Member at T2 Biosystems, Inc. In this role, he contributes to the governance of the company by bringing his expertise in the health technology sector. John plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.